Accelerated Antibody Discovery Targeting the SARS-CoV-2 Spike Protein for COVID-19 Therapeutic Potential

Answer a few questions below, and you'll get a downloadable report of Abveris's anti-SARS-CoV2 mAb discovery campaign. This document highlights the parallel workflows of our accelerated antibody discovery platform, as well as the sequences of human and murine SARS-CoV2-specific antibodies isolated from Alloy Mice and DiversimAb, respectively, for unrestricted use.